Moleculin Historical Financial Ratios

MBRX Stock  USD 1.27  0.01  0.79%   
Moleculin Biotech is lately reporting on over 106 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Moleculin Biotech financial condition quickly.
Quick RatioCurrent Ratio
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moleculin Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Moleculin Stock please use our How to Invest in Moleculin Biotech guide.

About Moleculin Financial Ratios Analysis

Moleculin BiotechFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Moleculin Biotech investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Moleculin financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Moleculin Biotech history.

Moleculin Biotech Financial Ratios Chart

At this time, Moleculin Biotech's Price Book Value Ratio is fairly stable compared to the past year.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
JavaScript chart by amCharts 3.21.15201620182020202220240.020.040.060.080.10.120.140.160.180.20.220.24 101002K4K6K8K10K12K14K16K18K20K22K 0.60.650.70.750.80.850.90.9511.051.11.151.21.25
JavaScript chart by amCharts 3.21.15Payables Turnovertotal: 0.9325131814680002Cash Per Sharetotal: 256.61165975116245Days Payables Outstandingtotal: 118.4KIncome Qualitytotal: 10.63575248414458

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.
Most ratios from Moleculin Biotech's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Moleculin Biotech current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moleculin Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Moleculin Stock please use our How to Invest in Moleculin Biotech guide.At this time, Moleculin Biotech's Price Book Value Ratio is fairly stable compared to the past year.
 2022 2024 2025 (projected)
Net Debt To EBITDA1.40.70.94
Intangibles To Total Assets0.190.340.45

Moleculin Biotech fundamentals Correlations

0.69-0.73-0.66-0.511.0-0.650.98-0.49-0.5-0.560.540.270.811.00.27-0.181.0-0.860.79-0.941.01.01.01.0-0.64
0.69-0.13-0.76-0.110.69-0.760.740.05-0.740.00.14-0.080.930.67-0.08-0.110.67-0.310.57-0.480.670.660.690.67-0.08
-0.73-0.130.10.53-0.730.1-0.670.91-0.020.85-0.33-0.63-0.25-0.75-0.63-0.02-0.750.71-0.380.86-0.75-0.77-0.74-0.750.98
-0.66-0.760.1-0.05-0.661.0-0.61-0.270.92-0.24-0.190.17-0.72-0.630.170.5-0.630.46-0.670.55-0.63-0.63-0.64-0.630.03
-0.51-0.110.53-0.05-0.51-0.06-0.570.57-0.20.66-0.49-0.22-0.34-0.52-0.22-0.6-0.520.62-0.460.47-0.52-0.51-0.52-0.520.45
1.00.69-0.73-0.66-0.51-0.650.98-0.49-0.5-0.560.540.270.811.00.27-0.181.0-0.860.79-0.941.01.01.01.0-0.64
-0.65-0.760.11.0-0.06-0.65-0.61-0.270.92-0.24-0.20.17-0.72-0.630.170.52-0.630.46-0.670.55-0.63-0.63-0.64-0.630.03
0.980.74-0.67-0.61-0.570.98-0.61-0.47-0.45-0.570.570.230.870.980.23-0.080.98-0.830.8-0.880.980.980.990.98-0.57
-0.490.050.91-0.270.57-0.49-0.27-0.47-0.340.94-0.21-0.65-0.09-0.52-0.65-0.29-0.520.5-0.130.61-0.52-0.53-0.51-0.520.91
-0.5-0.74-0.020.92-0.2-0.50.92-0.45-0.34-0.380.080.17-0.61-0.470.170.45-0.470.26-0.360.41-0.46-0.47-0.47-0.46-0.02
-0.560.00.85-0.240.66-0.56-0.24-0.570.94-0.38-0.5-0.52-0.21-0.59-0.52-0.23-0.590.64-0.30.62-0.6-0.6-0.58-0.60.81
0.540.14-0.33-0.19-0.490.54-0.20.57-0.210.08-0.5-0.030.430.54-0.03-0.230.54-0.740.67-0.450.550.530.550.55-0.18
0.27-0.08-0.630.17-0.220.270.170.23-0.650.17-0.52-0.03-0.060.291.00.130.29-0.21-0.1-0.470.290.30.280.29-0.7
0.810.93-0.25-0.72-0.340.81-0.720.87-0.09-0.61-0.210.43-0.060.8-0.06-0.090.8-0.580.76-0.590.80.780.810.8-0.14
1.00.67-0.75-0.63-0.521.0-0.630.98-0.52-0.47-0.590.540.290.80.29-0.171.0-0.870.79-0.951.01.01.01.0-0.66
0.27-0.08-0.630.17-0.220.270.170.23-0.650.17-0.52-0.031.0-0.060.290.130.29-0.21-0.1-0.470.290.30.280.29-0.7
-0.18-0.11-0.020.5-0.6-0.180.52-0.08-0.290.45-0.23-0.230.13-0.09-0.170.13-0.170.2-0.210.21-0.17-0.18-0.16-0.17-0.05
1.00.67-0.75-0.63-0.521.0-0.630.98-0.52-0.47-0.590.540.290.81.00.29-0.17-0.870.79-0.951.01.01.01.0-0.66
-0.86-0.310.710.460.62-0.860.46-0.830.50.260.64-0.74-0.21-0.58-0.87-0.210.2-0.87-0.760.84-0.87-0.87-0.86-0.870.59
0.790.57-0.38-0.67-0.460.79-0.670.8-0.13-0.36-0.30.67-0.10.760.79-0.1-0.210.79-0.76-0.640.790.770.790.79-0.21
-0.94-0.480.860.550.47-0.940.55-0.880.610.410.62-0.45-0.47-0.59-0.95-0.470.21-0.950.84-0.64-0.95-0.96-0.94-0.950.81
1.00.67-0.75-0.63-0.521.0-0.630.98-0.52-0.46-0.60.550.290.81.00.29-0.171.0-0.870.79-0.951.01.01.0-0.66
1.00.66-0.77-0.63-0.511.0-0.630.98-0.53-0.47-0.60.530.30.781.00.3-0.181.0-0.870.77-0.961.01.01.0-0.68
1.00.69-0.74-0.64-0.521.0-0.640.99-0.51-0.47-0.580.550.280.811.00.28-0.161.0-0.860.79-0.941.01.01.0-0.64
1.00.67-0.75-0.63-0.521.0-0.630.98-0.52-0.46-0.60.550.290.81.00.29-0.171.0-0.870.79-0.951.01.01.0-0.66
-0.64-0.080.980.030.45-0.640.03-0.570.91-0.020.81-0.18-0.7-0.14-0.66-0.7-0.05-0.660.59-0.210.81-0.66-0.68-0.64-0.66
Click cells to compare fundamentals

Moleculin Biotech Account Relationship Matchups

Moleculin Biotech fundamentals Accounts

202020212022202320242025 (projected)
Ptb Ratio2.650.630.580.980.880.92
Book Value Per Share27.0644.0927.3713.215.1814.42
Free Cash Flow Yield(0.39)(0.38)(0.91)(0.95)(1.09)(1.04)
Operating Cash Flow Per Share(27.07)(10.58)(14.49)(12.2)(10.98)(11.53)
Capex To Depreciation1.880.120.520.981.122.06
Pb Ratio2.650.630.580.980.880.92
Free Cash Flow Per Share(27.65)(10.59)(14.53)(12.26)(11.04)(11.59)
Roic(0.65)(0.16)(0.55)(0.94)(0.85)(0.89)
Net Income Per Share(22.85)(4.94)(14.37)(15.07)(13.56)(14.24)
Days Of Inventory On Hand2.4K(63.17)(36.17)0.0028740.0033050.00314
Payables Turnover0.250.190.110.05080.04580.0778
Cash Per Share23.1239.5722.6311.9213.7113.02
Pocfratio(2.65)(2.64)(1.1)(1.06)(0.95)(1.0)
Capex To Operating Cash Flow(0.0212)(0.001003)(0.002424)(0.005145)(0.004631)(0.004862)
Pfcf Ratio(2.59)(2.64)(1.09)(1.05)(0.95)(0.99)
Days Payables Outstanding1.4K1.9K3.4K7.2K8.3K7.6K
Income Quality1.021.190.950.810.730.76
Roe(0.84)(0.11)(0.53)(1.14)(1.31)(1.25)
Ev To Operating Cash Flow(1.81)1.10.45(0.1)(0.0922)(0.0968)
Pe Ratio(3.14)(5.64)(1.11)(0.85)(0.77)(0.81)
Return On Tangible Assets(0.84)(0.12)(0.59)(1.1)(0.99)(1.04)
Ev To Free Cash Flow(1.77)1.090.45(0.1)(0.0918)(0.0963)
Intangibles To Total Assets0.380.130.190.290.340.45
Net Debt To E B I T D A0.780.763.11.40.70.94
Current Ratio5.8920.029.463.863.474.69
Tangible Book Value Per Share10.0737.8721.527.556.813.3
Graham Number117.9470.0494.0866.8976.9273.08
Shareholders Equity Per Share27.0644.0927.3713.215.1814.42
Capex Per Share0.570.01060.03510.06280.07220.0686
Graham Net Net7.3636.7319.885.815.234.97
Interest Debt Per Share0.420.08870.240.290.330.32
Enterprise Value Over E B I T D A(1.65)0.910.41(0.0837)(0.0753)(0.0791)
Price Earnings Ratio(3.14)(5.64)(1.11)(0.85)(0.77)(0.81)
Operating Cycle2.4K(63.17)(36.17)0.0028740.0033050.00314
Price Book Value Ratio2.650.630.580.980.880.92
Price Earnings To Growth Ratio0.140.072(0.005795)(0.18)(0.2)(0.19)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Moleculin Stock Analysis

When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…